Bausch Health Companies Inc.
Bausch Health Companies Inc. (BHC.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BHC.TO · as of Jun 8, 2026
Key Statistics
Explore Bausch Health Companies Inc. Data
bhc.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 20 · Buy rate: 35.0%
Competitors & Peers
bhc.to competitorsBHC.TO
CPH.TO
CRON.TO
CURA.TO
EPIC.CN
GRIN.CNStock Performance
Full HistoryAbout Bausch Health Companies Inc.
Bausch Health Companies Inc. together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therap…
what is bausch health companies inc. · bhc.to stock overview · bausch health companies inc. company profile · who is bausch health companies inc. ceo · bhc.to TSX · bausch health companies inc. headquarters · bausch health companies inc. business segments
About Stock Overview & Key Data
Bausch Health Companies Inc. (BHC.TO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on TSX since Apr 3, 1996. As of the latest trading session, BHC.TO stock price is $7.49, with a market capitalization of $2.8B. The stock has returned +12.46% over the past 12 months and -21.41% year-to-date.
According to 20 Wall Street analysts, the consensus rating for Bausch Health Companies Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Bausch Health Companies Inc. reported revenue of $10.4B and net income of $159.7M. For detailed data — including Bausch Health Companies Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bausch Health Companies Inc. (BHC.TO) stock price is $7.49. The stock is traded on TSX under the ticker symbol BHC.TO. The 52-week range is $6.29 – $11.97.